Crystalline pi3 kinase inhibitors

Crystalline pi3 kinase inhibitors

There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COPMANS ALEX HERMAN, LEYS CARINA, FILLIERS WALTER FERDINAND MARIA, NIESTE PATRICK HUBERT J, VANHOUTTE FILIP MARCEL C, BROECKX RUDY LAURENT MARIA
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COPMANS ALEX HERMAN
LEYS CARINA
FILLIERS WALTER FERDINAND MARIA
NIESTE PATRICK HUBERT J
VANHOUTTE FILIP MARCEL C
BROECKX RUDY LAURENT MARIA
description There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN104302650A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN104302650A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN104302650A3</originalsourceid><addsrcrecordid>eNrjZFB0LqosLknMycnMS1UoyDRWyM7MSyxOVcjMy8hMyizJLyrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBibGBkZmpgaOxsSoAQCGICWe</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline pi3 kinase inhibitors</title><source>esp@cenet</source><creator>COPMANS ALEX HERMAN ; LEYS CARINA ; FILLIERS WALTER FERDINAND MARIA ; NIESTE PATRICK HUBERT J ; VANHOUTTE FILIP MARCEL C ; BROECKX RUDY LAURENT MARIA</creator><creatorcontrib>COPMANS ALEX HERMAN ; LEYS CARINA ; FILLIERS WALTER FERDINAND MARIA ; NIESTE PATRICK HUBERT J ; VANHOUTTE FILIP MARCEL C ; BROECKX RUDY LAURENT MARIA</creatorcontrib><description>There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150121&amp;DB=EPODOC&amp;CC=CN&amp;NR=104302650A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150121&amp;DB=EPODOC&amp;CC=CN&amp;NR=104302650A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COPMANS ALEX HERMAN</creatorcontrib><creatorcontrib>LEYS CARINA</creatorcontrib><creatorcontrib>FILLIERS WALTER FERDINAND MARIA</creatorcontrib><creatorcontrib>NIESTE PATRICK HUBERT J</creatorcontrib><creatorcontrib>VANHOUTTE FILIP MARCEL C</creatorcontrib><creatorcontrib>BROECKX RUDY LAURENT MARIA</creatorcontrib><title>Crystalline pi3 kinase inhibitors</title><description>There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB0LqosLknMycnMS1UoyDRWyM7MSyxOVcjMy8hMyizJLyrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBibGBkZmpgaOxsSoAQCGICWe</recordid><startdate>20150121</startdate><enddate>20150121</enddate><creator>COPMANS ALEX HERMAN</creator><creator>LEYS CARINA</creator><creator>FILLIERS WALTER FERDINAND MARIA</creator><creator>NIESTE PATRICK HUBERT J</creator><creator>VANHOUTTE FILIP MARCEL C</creator><creator>BROECKX RUDY LAURENT MARIA</creator><scope>EVB</scope></search><sort><creationdate>20150121</creationdate><title>Crystalline pi3 kinase inhibitors</title><author>COPMANS ALEX HERMAN ; LEYS CARINA ; FILLIERS WALTER FERDINAND MARIA ; NIESTE PATRICK HUBERT J ; VANHOUTTE FILIP MARCEL C ; BROECKX RUDY LAURENT MARIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN104302650A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>COPMANS ALEX HERMAN</creatorcontrib><creatorcontrib>LEYS CARINA</creatorcontrib><creatorcontrib>FILLIERS WALTER FERDINAND MARIA</creatorcontrib><creatorcontrib>NIESTE PATRICK HUBERT J</creatorcontrib><creatorcontrib>VANHOUTTE FILIP MARCEL C</creatorcontrib><creatorcontrib>BROECKX RUDY LAURENT MARIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COPMANS ALEX HERMAN</au><au>LEYS CARINA</au><au>FILLIERS WALTER FERDINAND MARIA</au><au>NIESTE PATRICK HUBERT J</au><au>VANHOUTTE FILIP MARCEL C</au><au>BROECKX RUDY LAURENT MARIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline pi3 kinase inhibitors</title><date>2015-01-21</date><risdate>2015</risdate><abstract>There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN104302650A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Crystalline pi3 kinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A25%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COPMANS%20ALEX%20HERMAN&rft.date=2015-01-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN104302650A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true